SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0649+0.6%3:42 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LT2011 who wrote (12384)9/6/2013 12:08:26 PM
From: NTTG1 Recommendation

Recommended By
Pogeu Mahone

  Read Replies (1) of 13111
 
If you look at the recent Seeking Alpha article you can see how unreal the hype is getting in the first few lines. While the orphan drug designation is true enough, the reality is that the pending PIII will be looking at a much less severe disease state. When you skip from orphan drug status to compassionate care w/o mentioning the long lost PII results, you know there is trouble in River City.

PVCT is a research and innovation company...where did that come from? How much innovative research do they crank out in a given year?

Not sure what 'significant recognition' is? Maybe it would be better if the oil and gas guys stuck with what they know, not what they hope for. Like the last news blurb to burp out of the machine, this one will not help SP

Yea, Dr W was 'eased' out, they could have expanded the board and kept him in place
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News